U.S. Pharmacist Diabetes Update

October 2018

Patch Subdues Stubborn Diabetic Foot Ulcers
A new study published in September in Lancet Diabetes and Endocrinology reports on a new, once-weekly patch comprised of platelets and fibrin that is applied to persistent, hard-to-heal diabetic foot ulcers. Study subjects with diabetic foot ulcers experienced shorter healing times than the control group, and the research team is hopeful that the findings will enhance healing options for hard-to-heal diabetic foot ulcers. Here are more details.

Improved Testing Differentiates Diabetes Diagnoses
Research results highlight a new rapid test that can distinguish between type 1 and type 2 diabetes. The study investigators emphasize the importance of accurate diagnosis to achieve positive outcomes in patients with either diagnosis, since these disease categories are associated with different care interventions. They also note that many patients are diagnosed with the wrong type of diabetes. Read more.

Addressing Diabetic Challenges in Transgender Individuals
New research findings reveal the need for considering modifiable risk factors associated with diabetes in transgender patients. The risks of increased cardiovascular disease and other adverse health effects that may result from gender-affirming hormone treatments pose enhanced perils in this population. More research into the adverse effects of hormone treatments, the scientists emphasize, is needed. Here are the details.

Connect With U.S. Pharmacist